ELTX ELICIO THERAPEUTICS INC Contract Awards 8-K Filing 2024 - Study Enrollment Complete Elicio Therapeutics, Inc. announced the completion of enrollment in its ELI-002 Phase 2 AMPLIFY-7P study on December 3, 2024.Get access to all SEC 8-K filings of the ELICIO THERAPEUTICS INC